Display Settings:


Send to:

Choose Destination

Links from PubMed

Accession: PRJNA93691 ID: 93691

Genomic approach to refine prognosis for adjuvant therapy in early stage non-small cell lung carcinoma (human)

See Genome Information for Homo sapiens
Abstract from paper - Potti A, et al Keywords: Outcome, recurrence, adjuvant therapy, Early stage Non-small cell Lung Cancer, Lung Metgene Predictor Overall design: Retrospective analysis of approximately 200 samples obtained from Duke, ACOSOG and CALGB to develop a Lung metagene predictor that would then be used to assess risk of recurrence and thus identify high risk patients with stage Ia non-small cell carcinoma who would be candidates for adjuvant chemotherapy
Project Data Type:Transcriptome or Gene expression
Attributes:Scope: Multiisolate; Material: Transcriptome; Capture: Whole; Method type: Array
Other Accessions:GEO:GSE3593
Project Data:
Resource NameNumber
of Links
Other datasets
GEO DataSets1
GEO Data Details
Data volume, Spots4398570
Data volume, Processed Mbytes96
  • Potti A et al., "Retraction: A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med 2006;355:570-80.", N Engl J Med, 2011 Mar 2;364(12):1176
  • Potti A et al., "A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.", N Engl J Med, 2006 Aug 10;355(6):570-80
Registration date: 10-Aug-2006
IGSP, Duke University

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...